Recap: PAVmed Q1 Earnings

PAVmed (NASDAQ:PAVM) reported its Q1 earnings results on Tuesday, May 16, 2023 at 05:00 PM. Here’s what investors…

PAVmed (NASDAQ:PAVM) reported its Q1 earnings results on Tuesday, May 16, 2023 at 05:00 PM.

Here’s what investors need to know about the announcement.

Earnings

PAVmed beat estimated earnings by 52.38%, reporting an EPS of $-0.1 versus an estimate of $-0.21.

Revenue was up $257 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.1 which was followed by a 6.68% drop in the share price the next day.

Here’s a look at PAVmed’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.25 -0.26 -0.23 -0.20
EPS Actual -0.15 -0.15 -0.17 -0.14
Revenue Estimate 270K 230K 260K 350K
Revenue Actual 112K 76K 0 189K

To track all earnings releases for PAVmed visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

From Campus To Catwalk: Abercrombie & Fitch Soars With Q1 Earnings Leap And Raised Forecasts

Abercrombie & Fitch shares surged after reporting a 22% year-on-year sales increase to $1.02 billion in Q1 FY24, surpassing analyst estimates. Adjusted EPS of $2.14 also beat expectations. The company raised its FY24 net sales growth outlook to 10% and operating margin to 14%. CEO Fran Horowitz attributed the success to strong assortments and marketing.

ANF